HomeSGX-LISTED COMPANIESCapital World Limited: 4Q2025 Earnings

Capital World Limited: 4Q2025 Earnings

Published on

spot_img

Capital World Limited reported a net loss for the full year, though its loss before income tax significantly narrowed, driven by the absence of substantial one-off impairments and improved cost discipline. Strategic developments include a significant acquisition by a new market entrant for retail units in Capital City Mall, marking a key turning point for the Group. The Group continues to manage liquidity cautiously amidst legal claims and an investigation that has frozen certain bank accounts.

• Discover how a landmark acquisition is poised to reshape a major property, ushering in a new era of retail vibrancy

• Uncover the Group’s determined efforts to navigate legal complexities and an ongoing investigation affecting its financial fluidity

• Explore the strategic property divestments and future plans that are laying the groundwork for the Group’s continued operations and potential for growth

LISTEN TO THE PODCAST BELOW:

Latest articles

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...

More like this

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...